AIFU Announces $31.6 Million Non-Brokered Private Placement

(NASDAQ:AIFU), GUANGZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) — AIFU Inc. (Nasdaq: AIFU) (the “Company” or “AIFU”), a leading AI-driven independent financial services platform in China, today announced that it has entered into a definitive share purchase agreement (the “Agreement”) with certain investors, pursuant to which the investors have agreed to subscribe for, and the […]

Unisync announces the retirement of Douglas F. Good as CEO

(TSX:UNI),(OTC US:USYNF),(Other OTC:USYNF), TORONTO, July 07, 2025 (GLOBE NEWSWIRE) — Unisync Corp. (“Unisync”) (TSX: UNI) (OTC: USYNF) today announced that Douglas F. Good, the Company's Chief Executive Officer, will retire as CEO and a director effective July 15, 2025. Chairman Tim Gu will assume the role of Executive Chairman, providing continuity and oversight as the

Brixton Metals Announces Flow-Through Private Placement of $2.3 Million

(TSX-V:BBB),(OTC US:BBBXF),(Other OTC:BBBXF), Not for distribution to United States Newswire Services or for dissemination in the United States VANCOUVER, British Columbia, July 07, 2025 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton“) is pleased to announce a non-brokered private placement offering (the “Offering”) of 17,692,308 flow-through common shares of

FuelCell Energy CEO Jason Few Applauds “One Big Beautiful Bill Act” as Catalyst for U.S. Clean Energy Leadership

(NasdaqGM:FCEL), DANBURY, Conn., July 07, 2025 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq: FCEL) President and CEO Jason Few has issued a statement praising the “One Big Beautiful Bill Act” (OBBBA) for its direct support of the fuel cell industry and its role in strengthening America's energy infrastructure, data center resilience, and clean manufacturing base.

Osisko Development Announces Positive Bulk Tonnage Ore Sorting Results for the Cariboo Gold Project

(TSX-V:ODV),(NYSE:ODV), HIGHLIGHTS X-ray transmission (XRT) ore sorter testwork of a ~80 tonne sample taken from the Cariboo underground achieved positive results consistent with 2025 FS parameters 42-55% waste rejection with 84-89% gold recovery achieved by sorting mid-size and oversize sample material including 10–30 mm and 30–70 mm size fractions, respectively Encouraging results from testing the

Yiviva Presents Phase 2b Results for YIV-906 in Combination with Sorafenib in Advanced Hepatocellular Carcinoma at ASCO and ESMO GI 2025

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Yiviva, a clinical-stage biotechnology company pioneering systems biology-driven therapeutics, announced data from its multi-regional, randomized, double-blind, placebo-controlled Phase 2b study of sorafenib (SORA) with or without YIV-906 in advanced hepatocellular carcinoma (HCC) patients with chronic hepatitis B (HBV+). Results were highlighted in an American Society of Clinical

Almaden Provides Update on Arbitration Procedure with Mexico

(TSX:AMM),(OTC US:AAUAF),(Other OTC:AAUAF), VANCOUVER, British Columbia, July 07, 2025 (GLOBE NEWSWIRE) — Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; OTCQB: AAUAF) announces that a public copy of the Memorial document (“Memorial”) that it filed in March of this year regarding its international arbitration proceedings (the “Claim”) under the Comprehensive and Progressive Agreement for

Quipt Home Medical Acquires Healthcare System Owned Medical Equipment Provider with $6.6 Million in Revenue, and Signs Preferred Provider Agreement Covering 20 Hospitals Across 4 States

(TSX:QIPT),(NASDAQ:QIPT), CINCINNATI, July 07, 2025 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (“Quipt” or the “Company“) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced it has acquired a full-service durable medical equipment (“DME“) provider, which is wholly owned by Ballad Health (the “Acquiree“). Ballad Health

Onco360 Has Been Selected as a National Specialty Pharmacy for Augtyro(TM) (repotrectinib)

LOUISVILLE, Ky., July 07, 2025 (GLOBE NEWSWIRE) — Onco360(R), the nation's leading independent specialty pharmacy, has added Augtyro(TM) (repotrectinib) manufactured by Bristol Myers Squibb to its comprehensive list of limited distribution therapies. Augtyro was initially approved on November 15, 2023, for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung

Copper Road announces the appointment of a new CEO

Copper Road announces the appointment of a new CEO GlobeNewswire July 07, 2025 TORONTO, July 07, 2025 (GLOBE NEWSWIRE) — Copper Road Resources Inc. (TSX-V: CRD) (“Copper Road” or the “Company”) announces the appointment of Mr. Brian Howlett as President and CEO, effectively immediately. Brian brings many years of experience in the junior exploration business

Scroll to Top